Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.

Rifabutin, 600 mg/day, was compared with a placebo in the early treatment of culture-proven Mycobacterium avium bacteremia in patients with AIDS. Following 14 days' treatment, bacteriological success, defined as a negative culture or a reduction in the number of CFU of M. avium organisms per millili...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Dautzenberg, B, Castellani, P, Pellegrin, J L, Vittecoq, D, Truffot-Pernot, C, Pirotta, N, Sassella, D
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 1996
主題:	Research Article
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163404/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8807071/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.7.1722
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!